0325: Prognosis of cardiac valve interventions among indigenous populations: a retrospective cohort study in New Caledonia  by Mikhaïl, Paul Barsoum et al.
© Elsevier Masson SAS. All rights reserved.
 
58 Archives of Cardiovascular Diseases Supplements (2016) 8, 51-65
0093
Early and late outcomes after trans-catheter aortic valve implantation
in patients with previous thoracic irradiation
Myriam Amsallem* (1), Claire Bouleti (2), Dominique Himbert (2),
Bernard Iung (2), Benjamin Alos (2), Walid Ghodbane (2), Marie-Pierre
Dilly (2), Patrick Nataf (2), Alec Vahanian (2)
(1) Stanford University, Palo Alto, Etats-Unis – (2) APHP-Hôpital Bichat-
Claude Bernard, Paris, France
*Corresponding author: mamsalle@stanford.edu (Myriam Amsallem)
Background Thoracic radiation therapy exposes to aortic stenosis and sur-
gery is associated with high morbi-mortality rates. Trans-catheter aortic valve
implantation (TAVI) may represent an interesting alternative, but experience
remains limited in this setting. We compared late outcome in a Radiation
group and a matched population undergoing TAVI and identified predictive
factors of late survival. 
Methods Between October 2006 and April 2011, 288 consecutive patients
underwent TAVI in our institution, of whom 27 had previous chest radiation.
They were matched 1:1 on age, sex and TAVI approach with a control popu-
lation. 
Results Mean age was 72±13 years in the Radiation group versus 75±9 in
the control group (p=0.52), 48% were male and 15% had a trans-apical
approach. Procedural success was 89% (n=24) in the Radiation group versus
96% (n=26) in controls and 30-day survival was 93±5% in both groups.
Follow-up was complete in all patients (median 3.4; interquartile range [2.6–
4.2] years). Five-years survival rates were 32±10% in the Radiation group and
41±11% in controls (p=0.27). In Radiation group, the cause of death was
respiratory failure secondary to radiation-induced fibrosis or sepsis in 54% of
cases. In multivariate analysis, we identified 3 predictive factors of late death
in Radiation group: 1 pre-procedural variable: the absence of Beta-blockers
therapy (HR=36.3 [4.1–325.2], p=0.001), and 2 post-procedural variables: cre-
atinine peak (HR=1.04 [1.02-1.07], p<0.0001) and infectious complication
(HR=7.8 [1.7-36.0], p=0.009). In the radiation group, 89% of survivors were
in NYHA class I-II at last follow-up. 
Conclusion Patients of the Radiation group displayed high mortality rates
even though not significantly different from the control population. In patients
with radiation valvular disease, the use of B-blockers was an independent pre-
dictor of late survival after TAVI which deserves further consideration. More-
over, respiratory failure was the main cause of death, emphasizing the need for
a careful pulmonary evaluation. Finally, we show a sustained improvement in
functional results after TAVI in this particular population.
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Aims Usefulness of exercise-stress echocardiography for risk-stratification
of asymptomatic patients with aortic stenosis (AS) is still debated (Class IIb
recommendation). The exercise-induced increase in transvalvular gradient has
been proposed as a prognostic factor but data are scarce. We sought to eval-
uate the additional prognostic value of echocardiographic parameters during
exercise-stress echocardiography.
Methods In this observational prospective study, we enrolled all consecu-
tive asymptomatic patients with moderate/severe AS and normal ejection frac-
tion who underwent an exercise-stress echocardiography at our institution.
Clinical and echocardiographic data at rest and at peak exercise were col-
lected. The composite primary outcome variable was the occurrence of AS
related events (symptoms or heart failure related to the AS or cardiovascular
death during follow-up).
Results Among the 121 patients enrolled, 35 (29%) had an abnormal exer-
cise test (occurrence of symptoms or abnormal blood pressure profile during
exercise) and were operated on within the following weeks. Eighty-six
patients (mean [quartiles]; age 67 [57-75] years, 68 male, mean gradient
46 [35-52]mmHg, aortic valve area 0,97 [0,82-1,11]) had a normal exercise
test and 39 (48%) reached the clinical endpoint during follow-up (17.5 [10.9-
36.4] months). The proposed threshold of 18mmHg mean gradient increase
had no prognostic value. In multivariate analysis, rest mean gradient (p<0.001;
HR 1.07 [1.03-1.11]) but not exercise-induced increase mean gradient (p=0.4;
HR 0.69 [0.29-1.65]) were predictive of outcome. 
Conclusion Exercise-induced increase in mean gradient was not predictive
of outcome in patients with normal exercise-test. Our results raise question
regarding the additional value and therefore the use of exercise-stress echocar-
diography for risk-stratification of asymptomatic patients with AS. 
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Introduction Data on the management of valvular heart disease is scarce
in the Pacific, a region where rheumatic heart disease remains endemic.
Methods Were included patients presenting to the single tertiary centre in
New Caledonia and who underwent heart valve surgery for the first time
(2005-2010). Clinical, echocardiographic, surgical data and outcomes were
collected in 2013. We explored potential factors associated with major cardio-
vascular events as a composite endpoint.
Results Among the 180 patients included, 95 (52.8%) were male; mean
age was 48.2 years (±19.3). 124 (78.9%) were Pacific islanders, 122 (70.9%)
presented in heart failure (70.9%) and 125 (69.4%) had rheumatic heart dis-
ease. 84 patients (46.7%) received a mechanical prosthetic valve. Median
follow-up was 4.7 years (IQR 3.5-6.7). Early postoperative mortality rate was
of 2.8%. The incidence of annual mortality was 31.75‰ (95% CI 19.77-
43.72) (including 25.78‰ cardiovascular death; 95 CI 15.01-36.55). The
annual incidences of stroke and severe bleeding were 38.23‰ (95% CI 24.07-
52.39) and 36.54‰ (95% CI 22.49-50.58), respectively. We did not identify
factors associated with outcomes according to the aetiology (rheumatic heart
disease versus other) or the procedure (mechanical prosthetic valve versus
other).
Conclusion In the Pacific heart valve interventions are mainly performed
in young patients with underlying rheumatic heart disease. Post-operative
mortality is low but morbidity remains high
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Introduction The non-invasive assessment of left ventricular (LV) filling
and LA pressure in patients with aortic stenosis (AS) remains challenging.
The aim of our study was to identify the echocardiographic parameters that
may predict elevated pulmonary capillary wedge pressures (PCWP) mea-
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sured by cardiac catheterization in patients with severe AS without other
valve disease. 
Methods and results From January 2010 to December 2012, we included
85 consecutive patients with severe AS scheduled for clinically indicated car-
diac catheterization study. Comprehensive transthoracic echocardiography
(TTE) was performed in all patients within 24 hours of the hemodynamic
study. Mean age was 75±9 years, 65% of them were male, 65%, 22% and
54% had respectively a history of hypertension, diabetes, and dyslipidemia.
NYHA functional class was ≥III in 63% of patients. By TTE, mean LV ejec-
tion fraction, max left atrial (LA) volume indexed, were respectively 60±9%,
and 38±16mL/m2. Mean mitral septal E/e’ ratio was 18.6±9. Cardiac cathe-
terization found 60% cases of coronary artery disease and the mean PCWP
was 13.5±7mmHg. As compared to patients with low PCWP (<13mmHg),
those with higher PCWP had similar LVEF, and AS severity but significantly
higher LA indexed volume (41±19 vs. 29±10mL/m2, p=0.004) and septal E/e’
(22.4±10 vs. 14.7±5, p=0.001). A maximal LA indexed volume >29ml/m2 pre-
dicted a PCWP>13mmhg with a sensitivity of 77% and a specificity of 62%
(area under the curve=0.73). Similarly, mitral annular septal E/e’ >12 pre-
dicted PCP>13mmHg with a sensitivity of 90% and a specificity of 60% (area
under the curve=0.73).
Conclusion In severe AS patients, maximal LA indexed volume >29/ml/m2
and E/e’ ratio >12, derived from TTE, appear as good markers of elevated
PCWP. Further studies are needed to investigate their prognostic values.
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Background Identifying subgroups of asymptomatic patients with aortic
stenosis (AS) who may benefit from early intervention is a critical challenge
due to the risk of sudden death and irreversible myocardial dysfunction
without preceding symptoms. In this study, we analyzed the determinants and
prognostic value of Galectin-3 in a large cohort of patients with AS.
Methods We included patients with at least mild degenerative AS enrolled
in 2 ongoing prospective clinical studies, COFRASA and GENERAC, aiming
at assessing the determinants of AS occurrence and progression.
Results Between November 2006 and July 2013, 583 patients were pro-
spectively enrolled. Severe AS was diagnosed in 312 (56%) patients
among whom 220 (38%) were symptomatic. Age (p<0.0001) and reduced
creatinine clearance (p<0.0001) were positively associated with Galectin-
3 level. 
No significant association was found between Galectin-3 and echocardio-
graphic parameters of AS severity including aortic valve area (p=0.41), mean
transvalvular gradient (p=0,27), and AS jet velocity (p=0.52). Galectin-3 did
not provide diagnostic evidence of severe AS (area under the curve=0.53).
Galectin-3 was not influenced by symptomatic status. Echocardiographic
parameters of LV remodeling were not associated with Galectin-3 in multivar-
iate analysis. Event-free survival analysis revealed no prognostic value of
Galectin-3.
Conclusions The main determinants of Galectin-3 level were age and renal
function. There was no association between Galectin-3 and symptomatic
status and echocardiographic parameters associated with LV remodeling.
Galectin-3 didn’t provide prognostic information on the occurrence of AS
related events. These results do not support the use of Galectin-3 in the deci-
sion making process of patients with AS.
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Background Percutaneous mitral valvuloplasty (PMV) has emerged as the
procedure of choice in treatment of mitral stenosis and has proved effective-
ness in cases of mitral restenosis after surgical commissurotomy Compared
with surgery, PMV is associated with shorter hospital stays, reduced patient
discomfort, and significantly lower costs. However, it is unknown whether
patients who developed symptomatic mitral restenosis after PMV may benefit
from repeat PMV (re-PMV) with safety.
Objectives This study was designed to evaluate the occurrence rate and the
predictive factors for severe complications following re-PMV.
Methods Retrospective study from a series of 40 procedures of re-PMV
with the Inoue balloon at 8±4 years after prior procedure, performed between
1996 and 2011. A clinical and ultrasound follow-up was achieved in
31 patients with a mean follow-up period of 43±26 months.
Results The mean age of patients was 43±11 years [23, 63]. 87.5% of the
population being female (5 men and 35 women). The immediate procedural
success was achieved in 31 patients (77.5%). A severe mitral regurgitation
(MR) was observed in 3 patients (7.5%). A cerebrovascular stroke occurred in
1 patient (2.5%). No procedure-related death or cardiac tamponade were
noted. Only a left atrial area ≤25cm 2 was linked to high risk of severe MR. At
long-term, mitral restenosis was observed in 13 patients (42%) at 53±30
months [9; 128] after re-PMV, 2 patients presented thromboembolic events
(6%) and no death. Only the male had been identified as a predictor of
restenosis.
Conclusion: The feasibility of re – PMV with a relatively high procedural
success rate and an acceptable complication profile makes it an appealing
therapeutic strategy for patients with recurrent valve stenosis.
The author hereby declares no conflict of interest
0015
Left ventricular rapid pacing: a new technique to simplify BAV and
TAVI procedures
Benjamin Faurie* 
GH Mutualiste, Grenoble, France
*Corresponding author: faurieb@gmail.com (Benjamin Faurie)
Aims The aim of this study is to demonstrate efficacy and safety of a new
technique for rapid pacing during balloon aortic valvuloplasty (BAV) and
Transaortic Valve Implantation (TAVI).
This study first describes the method used safely and successfully for BAV
and TAVI in a fragile adult population.
Methods and results these technique consist in a left ventricular pacing
through the 0.35 inch back up guidewire inserted into the left ventricule. The
cathode of an external pacemaker was placed on the external end of the 0.35’
wire using an alligator clamp. The anode was placed (also using an alligator
clamp) on a small needle piercing the subcutaneous tissue at the site of the
anesthetized groin.
The balloon or the TAVI catheter provides the necessary insulation.
We performed consecutively 100 cases of BAV and TAVI. All cases were
successfully conducted with a one for one pacing (160 to 200/mn). That’s how
we obtain a significant blood pressure drop in all cases with a mean systolic
pressure during stimulation of 45mmHg. The time procedure was 38mn for
BAV and 65mn for TAVI. Only three patients underwent a venous temporary
pacemaker at the end of procedure for conduction disturbances. All cases of
TAVI (34) underwent a femoral venous catheter as a central catheter while the
BAV population did not have a venous femoral puncture. No venous vascular
complication or tamponade was observed in our population.
